Selected research
Industry Research
Teriparatide API Industry Research Report 2026
Market perspective
The global Teriparatide API market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Teriparatide API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Teriparatide API is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Teriparatide API is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Teriparatide API include Zhejiang Paipeptide Biopharmaceuticals, Xinlitai (Suzhou) Pharmaceuticals, Suzhou Tianma Pharmaceutical Group, Shenzhen Jianyuan Pharmaceutical Technology, Shanghai United Cell Bioengineering, Chengdu Shengnuo Biopharmaceuticals, Rochem International, Intas Pharmaceuticals and Gedeon Richter, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Teriparatide API market in terms of revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Teriparatide API Market by Company
Zhejiang Paipeptide Biopharmaceuticals
Xinlitai (Suzhou) Pharmaceuticals
Suzhou Tianma Pharmaceutical Group
Shenzhen Jianyuan Pharmaceutical Technology
Shanghai United Cell Bioengineering
Chengdu Shengnuo Biopharmaceuticals
Rochem International
Intas Pharmaceuticals
Gedeon Richter
Teriparatide API Segment by Type
Long-acting Preparations
Pre-filled Injection Pens
Half-week Powder Injections
Teriparatide API Segment by Application
Osteoporosis Treatment
Laboratory Research
Teriparatide API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Teriparatide API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Teriparatide API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Teriparatide API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Teriparatide API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Teriparatide API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Teriparatide API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Long-acting Preparations
- Pre-filled Injection Pens
- Half-week Powder Injections
Applications
- Osteoporosis Treatment
- Laboratory Research
Companies covered
- Zhejiang Paipeptide Biopharmaceuticals
- Xinlitai (Suzhou) Pharmaceuticals
- Suzhou Tianma Pharmaceutical Group
- Shenzhen Jianyuan Pharmaceutical Technology
- Shanghai United Cell Bioengineering
- Chengdu Shengnuo Biopharmaceuticals
- Rochem International
- Intas Pharmaceuticals
- Gedeon Richter
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Teriparatide API Market Size (2021-2032)
- 2.2.2 Global Teriparatide API Sales (2021-2032)
- 2.2.3 Global Teriparatide API Market Average Price (2021-2032)
- 2.3 Teriparatide API by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Long-acting Preparations
- 2.3.3 Pre-filled Injection Pens
- 2.3.4 Half-week Powder Injections
- 2.4 Teriparatide API by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Osteoporosis Treatment
- 2.4.3 Laboratory Research
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Teriparatide API Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Teriparatide API Sales (t) of Manufacturers (2021-2026)
- 3.3 Global Teriparatide API Revenue of Manufacturers (2021-2026)
- 3.4 Global Teriparatide API Average Price by Manufacturers (2021-2026)
- 3.5 Global Teriparatide API Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Teriparatide API, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Teriparatide API, Product Type & Application
- 3.8 Global Manufacturers of Teriparatide API, Established Date
- 3.9 Global Teriparatide API Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhejiang Paipeptide Biopharmaceuticals
- 4.1.1 Zhejiang Paipeptide Biopharmaceuticals Company Information
- 4.1.2 Zhejiang Paipeptide Biopharmaceuticals Business Overview
- 4.1.3 Zhejiang Paipeptide Biopharmaceuticals Teriparatide API Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zhejiang Paipeptide Biopharmaceuticals Teriparatide API Product Portfolio
- 4.1.5 Zhejiang Paipeptide Biopharmaceuticals Recent Developments
- 4.2 Xinlitai (Suzhou) Pharmaceuticals
- 4.2.1 Xinlitai (Suzhou) Pharmaceuticals Company Information
- 4.2.2 Xinlitai (Suzhou) Pharmaceuticals Business Overview
- 4.2.3 Xinlitai (Suzhou) Pharmaceuticals Teriparatide API Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Xinlitai (Suzhou) Pharmaceuticals Teriparatide API Product Portfolio
- 4.2.5 Xinlitai (Suzhou) Pharmaceuticals Recent Developments
- 4.3 Suzhou Tianma Pharmaceutical Group
- 4.3.1 Suzhou Tianma Pharmaceutical Group Company Information
- 4.3.2 Suzhou Tianma Pharmaceutical Group Business Overview
- 4.3.3 Suzhou Tianma Pharmaceutical Group Teriparatide API Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Suzhou Tianma Pharmaceutical Group Teriparatide API Product Portfolio
- 4.3.5 Suzhou Tianma Pharmaceutical Group Recent Developments
- 4.4 Shenzhen Jianyuan Pharmaceutical Technology
- 4.4.1 Shenzhen Jianyuan Pharmaceutical Technology Company Information
- 4.4.2 Shenzhen Jianyuan Pharmaceutical Technology Business Overview
- 4.4.3 Shenzhen Jianyuan Pharmaceutical Technology Teriparatide API Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Shenzhen Jianyuan Pharmaceutical Technology Teriparatide API Product Portfolio
- 4.4.5 Shenzhen Jianyuan Pharmaceutical Technology Recent Developments
- 4.5 Shanghai United Cell Bioengineering
- 4.5.1 Shanghai United Cell Bioengineering Company Information
- 4.5.2 Shanghai United Cell Bioengineering Business Overview
- 4.5.3 Shanghai United Cell Bioengineering Teriparatide API Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Shanghai United Cell Bioengineering Teriparatide API Product Portfolio
- 4.5.5 Shanghai United Cell Bioengineering Recent Developments
- 4.6 Chengdu Shengnuo Biopharmaceuticals
- 4.6.1 Chengdu Shengnuo Biopharmaceuticals Company Information
- 4.6.2 Chengdu Shengnuo Biopharmaceuticals Business Overview
- 4.6.3 Chengdu Shengnuo Biopharmaceuticals Teriparatide API Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Chengdu Shengnuo Biopharmaceuticals Teriparatide API Product Portfolio
- 4.6.5 Chengdu Shengnuo Biopharmaceuticals Recent Developments
- 4.7 Rochem International
- 4.7.1 Rochem International Company Information
- 4.7.2 Rochem International Business Overview
- 4.7.3 Rochem International Teriparatide API Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Rochem International Teriparatide API Product Portfolio
- 4.7.5 Rochem International Recent Developments
- 4.8 Intas Pharmaceuticals
- 4.8.1 Intas Pharmaceuticals Company Information
- 4.8.2 Intas Pharmaceuticals Business Overview
- 4.8.3 Intas Pharmaceuticals Teriparatide API Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Intas Pharmaceuticals Teriparatide API Product Portfolio
- 4.8.5 Intas Pharmaceuticals Recent Developments
- 4.9 Gedeon Richter
- 4.9.1 Gedeon Richter Company Information
- 4.9.2 Gedeon Richter Business Overview
- 4.9.3 Gedeon Richter Teriparatide API Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Gedeon Richter Teriparatide API Product Portfolio
- 4.9.5 Gedeon Richter Recent Developments
5 Global Teriparatide API Market Scenario by Region
- 5.1 Global Teriparatide API Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Teriparatide API Sales by Region: 2021-2032
- 5.2.1 Global Teriparatide API Sales by Region: 2021-2026
- 5.2.2 Global Teriparatide API Sales by Region: 2027-2032
- 5.3 Global Teriparatide API Revenue by Region: 2021-2032
- 5.3.1 Global Teriparatide API Revenue by Region: 2021-2026
- 5.3.2 Global Teriparatide API Revenue by Region: 2027-2032
- 5.4 North America Teriparatide API Market Facts & Figures by Country
- 5.4.1 North America Teriparatide API Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Teriparatide API Sales by Country (2021-2032)
- 5.4.3 North America Teriparatide API Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Teriparatide API Market Facts & Figures by Country
- 5.5.1 Europe Teriparatide API Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Teriparatide API Sales by Country (2021-2032)
- 5.5.3 Europe Teriparatide API Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Teriparatide API Market Facts & Figures by Country
- 5.6.1 Asia Pacific Teriparatide API Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Teriparatide API Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Teriparatide API Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Teriparatide API Market Facts & Figures by Country
- 5.7.1 South America Teriparatide API Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Teriparatide API Sales by Country (2021-2032)
- 5.7.3 South America Teriparatide API Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Teriparatide API Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Teriparatide API Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Teriparatide API Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Teriparatide API Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Teriparatide API Sales by Type (2021-2032)
- 6.1.1 Global Teriparatide API Sales by Type (2021-2032) & (t)
- 6.1.2 Global Teriparatide API Sales Market Share by Type (2021-2032)
- 6.2 Global Teriparatide API Revenue by Type (2021-2032)
- 6.2.1 Global Teriparatide API Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Teriparatide API Revenue Market Share by Type (2021-2032)
- 6.3 Global Teriparatide API Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Teriparatide API Sales by Application (2021-2032)
- 7.1.1 Global Teriparatide API Sales by Application (2021-2032) & (t)
- 7.1.2 Global Teriparatide API Sales Market Share by Application (2021-2032)
- 7.2 Global Teriparatide API Revenue by Application (2021-2032)
- 7.2.1 Global Teriparatide API Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Teriparatide API Revenue Market Share by Application (2021-2032)
- 7.3 Global Teriparatide API Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Teriparatide API Value Chain Analysis
- 8.1.1 Teriparatide API Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Teriparatide API Production Mode & Process
- 8.2 Teriparatide API Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Teriparatide API Distributors
- 8.2.3 Teriparatide API Customers
9 Global Teriparatide API Analyzing Market Dynamics
- 9.1 Teriparatide API Industry Trends
- 9.2 Teriparatide API Industry Drivers
- 9.3 Teriparatide API Industry Opportunities and Challenges
- 9.4 Teriparatide API Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst